The MIMIX™ Difference

MIMIX therapies deliver powerful benefits

 
Vaxess-MIMIX-graphic.png
Vaxess-Mimix-logo-white-wide.png
 

MIMIX™ therapies are transforming medicinal delivery. Once placed on the skin, each MIMIX™ patch delivers bioactive tips into the immunologically active dermal barrier. These bioactive tips gradually dissolve into the body after the patch is removed, releasing their payload of vaccines and therapeutics over time.

 

Facilitating simple, pain-free, broadly distributed delivery of vaccines and other biologics.

MIMIX is designed for efficient, remote delivery and simple, short wear time. At-home, in the field, or intro extreme environments—MIMIX goes where traditional vaccines can’t.

The slow-release, bioactive tips that make this possible are made from silk fibroin proteins—unlike any other existing technology.

MIMIX™ therapies are shelf-stable, do not require refrigeration, and can be simply applied, virtually pain free. The patch is applied with a preloaded applicator and removed after a few minutes; no sharps bin required.

Compatible with a broad array of vaccines and biologics, MIMIX™ therapies enable optimized distribution at a significantly lower cost.

 
 
 

 MIMIX™ Microarray in Action

Once placed on the skin, each MIMIX™patch delivers a microarray of slow-release, bioactive tips into the body's most effective immunological organ: the dermal barrier. These bioactive tips gradually dissolve into the body after the patch is removed.

 

Easy and Accessible

MIMIX is designed for efficient, remote delivery and simple, short wear time. At home, in the field, or into extreme environments - MIMIX goes where traditional vaccines can't.

Introducing the MIMIX Platform

Facilitating simple, pain-free, broadly distributed delivery of vaccines and other biologics.

 

Revolutionary Care At Your Doorstep

Vaxess’s MIMIX platform will allow vaccines and complex biologics to be uniquely and easily delivered at home.

 
VAXESS-icon-distribution.png

Optimized Distribution

Scalable manufacturing of shelf-stable, non-cold chain MIMIX vaccines and therapeutics drive availability to people and communities in the US and around the world.

VAXESS-icon-patient-10.png

Improved experience for people

Pain-free, needle-free, easy-to-use.